The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors

• Vladimer Darsalia,
• Martin Larsson,
• Thomas Klein,
• Cesare Patrone

Affiliations

Vladimer Darsalia

Department of Clinical Science and Education, Södersjukhuset, Internal Medicine, Karolinska Institutet

Martin Larsson

Department of Clinical Science and Education, Södersjukhuset, Internal Medicine, Karolinska Institutet

Thomas Klein

Boehringer Ingelheim Pharma GmbH & Co. KG

Cesare Patrone

Department of Clinical Science and Education, Södersjukhuset, Internal Medicine, Karolinska Institutet